Lisa Swanson, MD: Insights on Maximum-use of Ruxolitinib Cream in Pediatric Patients with Atopic Dermatitis
Lisa Swanson, MD, JCAD’s Section Editor of Pediatric Dermatology, shares her thoughts on new research evaluating maximum-use conditions for topical ruxolitinib cream in pediatric patients (2 to 11 years) with atopic dermatitis. Reference:
James Song, MD: Personalizing Treatment for Atopic Dermatitis
Looking to the future of AD treatment, Dr. Song discusses the unmet need of predicting treatment responses in patients with atopic dermatitis, with the aim of avoiding the trial-and-error process of trying multiple medications.
James Song, MD, FAAD: Checking in on Long-term Safety Data on JAK Inhibitors for Atopic Dermatitis
Dr. Song discusses the latest safety data on topical and oral JAK inhibitors for patients with atopic dermatitis.
James Del Rosso, DO: Evaluating Effective Topical Therapies for Atopic Dermatitis
Dr. Del Rosso discusses the current topical treatments available for patients with atopic dermatitis that have shown consistent efficacy with limited adverse events.
Raj Chovatiya, MD, PhD: Atopic Dermatitis Patient Counseling for Moisturization
Dr. Chovatiya discusses the effectiveness of providing a moisturizer in combination with a topical or systemic therapy to achieve clear skin regardless of disease severity.